UBS Group
ADAG

UBS Group’s Adagene ADAG Stock Holding History

UBS Group’s Portfolio ADAG Stock Details ADAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$521K Buy
124,063
+120,061
+3,000% +$452K ﹤0.01% 6200
2026
Q1 		$15.7K Buy
4,002
+1,449
+57% +$4.19K ﹤0.01% 8106
2025
Q4 		$4.83K Sell
2,553
-253
-9% -$467 ﹤0.01% 8773
2025
Q3 		$5.58K Buy
+2,806
New +$5.74K ﹤0.01% 8853
2024
Q3 		– Sell
-164
Closed -$502 – 9445
2024
Q2 		$502 Sell
164
-250
-60% -$670 ﹤0.01% 8896
2024
Q1 		$1.16K Buy
414
+413
+41,300% +$1.29K ﹤0.01% 8209
2023
Q4 		$2 Buy
+1
New +$2 ﹤0.01% 9186
2021
Q4 		– Sell
-1,225
Closed -$18K – 10212
2021
Q3 		$18K Sell
1,225
-837
-41% -$13.7K ﹤0.01% 7265
2021
Q2 		$28K Buy
2,062
+1,785
+644% +$24.8K ﹤0.01% 6998
2021
Q1 		$5K Buy
+277
New +$6.31K ﹤0.01% 8299

Other funds holding ADAG

JT
Jupiter Topco New York $245B AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EAM
Exome Asset Management New York $162M AUM 259.04% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

UBS Group's ADAG Position: Q2 2026 in Review

UBS Group increased its Adagene (ADAG) stake by 3,000% in Q2 2026, buying an estimated $452K and bringing the position to 124,063 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #6200.

UBS Group first reported a position in ADAG in Q1 2021 and has held it in 10 quarters since. 35 funds tracked by Wall St. Rank hold ADAG as of Q2 2026.

  • UBS Group held 124,063 shares of Adagene worth $521K as of Q2 2026.
  • UBS Group bought 120,061 Adagene shares in Q2 2026, an estimated $452K.
  • Adagene made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6200 holding.
  • UBS Group first reported a position in Adagene in Q1 2021 and has held it in 10 quarters since.
  • 35 funds tracked by Wall St. Rank held Adagene as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.